Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Intravenous Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Intravenous Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Intravenous Drug Delivery Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 Intravenous Drug Delivery Devices Product Introduction
1.2 Global Intravenous Drug Delivery Devices Market Size Forecast
1.2.1 Global Intravenous Drug Delivery Devices Sales Value (2020-2031)
1.2.2 Global Intravenous Drug Delivery Devices Sales Volume (2020-2031)
1.2.3 Global Intravenous Drug Delivery Devices Sales Price (2020-2031)
1.3 Intravenous Drug Delivery Devices Market Trends & Drivers
1.3.1 Intravenous Drug Delivery Devices Industry Trends
1.3.2 Intravenous Drug Delivery Devices Market Drivers & Opportunity
1.3.3 Intravenous Drug Delivery Devices Market Challenges
1.3.4 Intravenous Drug Delivery Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Intravenous Drug Delivery Devices Players Revenue Ranking (2024)
2.2 Global Intravenous Drug Delivery Devices Revenue by Company (2020-2025)
2.3 Global Intravenous Drug Delivery Devices Players Sales Volume Ranking (2024)
2.4 Global Intravenous Drug Delivery Devices Sales Volume by Company Players (2020-2025)
2.5 Global Intravenous Drug Delivery Devices Average Price by Company (2020-2025)
2.6 Key Manufacturers Intravenous Drug Delivery Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Intravenous Drug Delivery Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Intravenous Drug Delivery Devices
2.9 Intravenous Drug Delivery Devices Market Competitive Analysis
2.9.1 Intravenous Drug Delivery Devices Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Intravenous Drug Delivery Devices Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Drug Delivery Devices as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Auto-injectors (Syringe and Cartridge Based)
3.1.2 Pen Injectors
3.1.3 Others
3.2 Global Intravenous Drug Delivery Devices Sales Value by Type
3.2.1 Global Intravenous Drug Delivery Devices Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Intravenous Drug Delivery Devices Sales Value, by Type (2020-2031)
3.2.3 Global Intravenous Drug Delivery Devices Sales Value, by Type (%) (2020-2031)
3.3 Global Intravenous Drug Delivery Devices Sales Volume by Type
3.3.1 Global Intravenous Drug Delivery Devices Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Intravenous Drug Delivery Devices Sales Volume, by Type (2020-2031)
3.3.3 Global Intravenous Drug Delivery Devices Sales Volume, by Type (%) (2020-2031)
3.4 Global Intravenous Drug Delivery Devices Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Nursing Homes
4.1.3 Home Care
4.1.4 Others
4.2 Global Intravenous Drug Delivery Devices Sales Value by Application
4.2.1 Global Intravenous Drug Delivery Devices Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Intravenous Drug Delivery Devices Sales Value, by Application (2020-2031)
4.2.3 Global Intravenous Drug Delivery Devices Sales Value, by Application (%) (2020-2031)
4.3 Global Intravenous Drug Delivery Devices Sales Volume by Application
4.3.1 Global Intravenous Drug Delivery Devices Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Intravenous Drug Delivery Devices Sales Volume, by Application (2020-2031)
4.3.3 Global Intravenous Drug Delivery Devices Sales Volume, by Application (%) (2020-2031)
4.4 Global Intravenous Drug Delivery Devices Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Intravenous Drug Delivery Devices Sales Value by Region
5.1.1 Global Intravenous Drug Delivery Devices Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Intravenous Drug Delivery Devices Sales Value by Region (2020-2025)
5.1.3 Global Intravenous Drug Delivery Devices Sales Value by Region (2026-2031)
5.1.4 Global Intravenous Drug Delivery Devices Sales Value by Region (%), (2020-2031)
5.2 Global Intravenous Drug Delivery Devices Sales Volume by Region
5.2.1 Global Intravenous Drug Delivery Devices Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Intravenous Drug Delivery Devices Sales Volume by Region (2020-2025)
5.2.3 Global Intravenous Drug Delivery Devices Sales Volume by Region (2026-2031)
5.2.4 Global Intravenous Drug Delivery Devices Sales Volume by Region (%), (2020-2031)
5.3 Global Intravenous Drug Delivery Devices Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Intravenous Drug Delivery Devices Sales Value, 2020-2031
5.4.2 North America Intravenous Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Intravenous Drug Delivery Devices Sales Value, 2020-2031
5.5.2 Europe Intravenous Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Intravenous Drug Delivery Devices Sales Value, 2020-2031
5.6.2 Asia Pacific Intravenous Drug Delivery Devices Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Intravenous Drug Delivery Devices Sales Value, 2020-2031
5.7.2 South America Intravenous Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Intravenous Drug Delivery Devices Sales Value, 2020-2031
5.8.2 Middle East & Africa Intravenous Drug Delivery Devices Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Intravenous Drug Delivery Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Intravenous Drug Delivery Devices Sales Value
6.2.1 Key Countries/Regions Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.2.2 Key Countries/Regions Intravenous Drug Delivery Devices Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.3.2 United States Intravenous Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Intravenous Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.4.2 Europe Intravenous Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Intravenous Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.5.2 China Intravenous Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.5.3 China Intravenous Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.6.2 Japan Intravenous Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Intravenous Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.7.2 South Korea Intravenous Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Intravenous Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.8.2 Southeast Asia Intravenous Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Intravenous Drug Delivery Devices Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Intravenous Drug Delivery Devices Sales Value, 2020-2031
6.9.2 India Intravenous Drug Delivery Devices Sales Value by Type (%), 2024 VS 2031
6.9.3 India Intravenous Drug Delivery Devices Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Baxter International
7.1.1 Baxter International Company Information
7.1.2 Baxter International Introduction and Business Overview
7.1.3 Baxter International Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Baxter International Intravenous Drug Delivery Devices Product Offerings
7.1.5 Baxter International Recent Development
7.2 Becton Dickinson and Company
7.2.1 Becton Dickinson and Company Company Information
7.2.2 Becton Dickinson and Company Introduction and Business Overview
7.2.3 Becton Dickinson and Company Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Becton Dickinson and Company Intravenous Drug Delivery Devices Product Offerings
7.2.5 Becton Dickinson and Company Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Pfizer Intravenous Drug Delivery Devices Product Offerings
7.3.5 Pfizer Recent Development
7.4 Schott
7.4.1 Schott Company Information
7.4.2 Schott Introduction and Business Overview
7.4.3 Schott Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Schott Intravenous Drug Delivery Devices Product Offerings
7.4.5 Schott Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Information
7.5.2 Johnson & Johnson Introduction and Business Overview
7.5.3 Johnson & Johnson Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Johnson & Johnson Intravenous Drug Delivery Devices Product Offerings
7.5.5 Johnson & Johnson Recent Development
7.6 Novartis
7.6.1 Novartis Company Information
7.6.2 Novartis Introduction and Business Overview
7.6.3 Novartis Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Novartis Intravenous Drug Delivery Devices Product Offerings
7.6.5 Novartis Recent Development
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Information
7.7.2 Novo Nordisk Introduction and Business Overview
7.7.3 Novo Nordisk Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Novo Nordisk Intravenous Drug Delivery Devices Product Offerings
7.7.5 Novo Nordisk Recent Development
7.8 B. Braun Melsungen AG
7.8.1 B. Braun Melsungen AG Company Information
7.8.2 B. Braun Melsungen AG Introduction and Business Overview
7.8.3 B. Braun Melsungen AG Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 B. Braun Melsungen AG Intravenous Drug Delivery Devices Product Offerings
7.8.5 B. Braun Melsungen AG Recent Development
7.9 Cardinal Health
7.9.1 Cardinal Health Company Information
7.9.2 Cardinal Health Introduction and Business Overview
7.9.3 Cardinal Health Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Cardinal Health Intravenous Drug Delivery Devices Product Offerings
7.9.5 Cardinal Health Recent Development
7.10 Teva Pharmaceuticals
7.10.1 Teva Pharmaceuticals Company Information
7.10.2 Teva Pharmaceuticals Introduction and Business Overview
7.10.3 Teva Pharmaceuticals Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Teva Pharmaceuticals Intravenous Drug Delivery Devices Product Offerings
7.10.5 Teva Pharmaceuticals Recent Development
7.11 Eli Lilly and Company
7.11.1 Eli Lilly and Company Company Information
7.11.2 Eli Lilly and Company Introduction and Business Overview
7.11.3 Eli Lilly and Company Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Eli Lilly and Company Intravenous Drug Delivery Devices Product Offerings
7.11.5 Eli Lilly and Company Recent Development
7.12 Gerresheimer
7.12.1 Gerresheimer Company Information
7.12.2 Gerresheimer Introduction and Business Overview
7.12.3 Gerresheimer Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Gerresheimer Intravenous Drug Delivery Devices Product Offerings
7.12.5 Gerresheimer Recent Development
7.13 Insulet Corporation
7.13.1 Insulet Corporation Company Information
7.13.2 Insulet Corporation Introduction and Business Overview
7.13.3 Insulet Corporation Intravenous Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Insulet Corporation Intravenous Drug Delivery Devices Product Offerings
7.13.5 Insulet Corporation Recent Development
8 Industry Chain Analysis
8.1 Intravenous Drug Delivery Devices Industrial Chain
8.2 Intravenous Drug Delivery Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Intravenous Drug Delivery Devices Sales Model
8.5.2 Sales Channel
8.5.3 Intravenous Drug Delivery Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
Published Date: 2024-01-17
Pages: 88
USD 2900.00
(Single User License)
The global market for Intravenous Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 89
USD 2900.00
(Single User License)
The global Intravenous Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 162
USD 4900.00
(Single User License)
The global Intravenous Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 91
USD 4250.00
(Single User License)
The global Intravenous Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 124
USD 2900.00
(Single User License)
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
Intravenous (IV) delivery is an injection or infusion method of drug administration, which means drugs are sent directly into your vein using a needle or tube.
Published: 2024-01-17
Pages: 88
The global market for Intravenous Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 89
The global Intravenous Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 162
The global Intravenous Drug Delivery Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 91
The global Intravenous Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 124
The global market for Intravenous Drug Delivery Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 140
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research